(Q48796906)

15 February 2018

title

Neuroprotective effects of the glutamate release inhibitor 619C89 in temporary middle cerebral artery occlusion (English)

1 reference

15 February 2018

author name string

Kawaguchi K

series ordinal

1

1 reference

15 February 2018

Graham SH

series ordinal

2

1 reference

15 February 2018

language of work or name

English

0 references

publication date

1 February 1997

1 reference

15 February 2018

published in

Brain Research

1 reference

15 February 2018

volume

749

1 reference

15 February 2018

issue

1

1 reference

15 February 2018

page(s)

131-134

1 reference

15 February 2018

Role of oxidants in ischemic brain damage

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901311-X

Attenuation of postischemic brain hypoperfusion and reperfusion injury by the cyclooxygenase-lipoxygenase inhibitor BW755C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901311-X

Limiting ischemic injury by inhibition of excitatory amino acid release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901311-X

A dose-response study of dextrorphan in permanent focal ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901311-X

BW619C89, a glutamate release inhibitor, protects against focal cerebral ischemic damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901311-X

Reversible middle cerebral artery occlusion without craniectomy in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901311-X

Secondary elevation of extracellular neurotransmitter amino acids in the reperfusion phase following focal cerebral ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901311-X

Reduction of glutamate release and protection against ischemic brain damage by BW 1003C87.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901311-X

The glutamate antagonist MK-801 reduces focal ischemic brain damage in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901311-X

Amino acid and purine release in rat brain following temporary middle cerebral artery occlusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901311-X

Cerebroprotective effect of BW619C89 after focal or global cerebral ischaemia in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901311-X

Phencyclidine and psychotomimetic sigma opiates: recent insights into their biochemical and physiological sites of action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901311-X

Intercellular adhesion molecule-1-deficient mice are less susceptible to cerebral ischemia-reperfusion injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901311-X

A semiautomated method for measuring brain infarct volume.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901311-X

Brain injury by global ischemia and reperfusion: a theoretical perspective on membrane damage and repair

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901311-X

10.1016/S0006-8993(96)01311-X

7 January 2021

Identifiers

DOI

1 reference

15 February 2018

1 reference

15 February 2018